Skip Navigation

Nephrology Dialysis Transplantation 2009 24(11):i; doi:10.1093/ndt/gfp548
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
PubMed
Right arrow PubMed Citation
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press [on behalf of ERA-EDTA]. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org


In this issue

The first 10% of the full text of this article appears below.

KIM-1 and NGAL are at present among the most frequently tested molecules in the clinical pursuit of biomarkers for the early diagnosis of acute kidney injury. Both molecules could be more reliable than the currently still accepted "gold standard" of the change in serum creatinine. NGAL is also a predictor of the iron status of the haemodialysis patient. Two original articles and an editorial comment address several aspects of these . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?